Jianjun Peng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 7
-
- Gastric Cancer Management and Outcomes 14
- Co-authors
- Yulong He (25 shared papers)Jianbo Xu (14 shared papers)Hui Gao (7 shared papers)Xinde Ou (5 shared papers)Jinning Ye (9 shared papers)Shirong Cai (13 shared papers)Zirui Zhao (3 shared papers)Kaiming Wu (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Cancer (2 papers)Oncotarget (2 papers)BMC Cancer (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jianjun Peng
76 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 584
- Oncology 372
- Molecular Biology 771
- Pulmonary and Respiratory Medicine 314
- Gastroenterology 48
Countries citing papers authored by Jianjun Peng
This map shows the geographic impact of Jianjun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Peng more than expected).
Fields of papers citing papers by Jianjun Peng
This network shows the impact of papers produced by Jianjun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Peng. The network helps show where Jianjun Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianjun Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 148 | |
| 2 | 2022 | 91 | |
| 3 | 2016 | 90 | |
| 4 | 2022 | 67 | |
| 5 | 2014 | 61 | |
| 6 | 2013 | 61 | |
| 7 | 2018 | 59 | |
| 8 | 2015 | 55 | |
| 9 | 2020 | 48 | |
| 10 | 2018 | 47 | |
| 11 | 2014 | 45 | |
| 12 | 2020 | 44 | |
| 13 | 2020 | 42 | |
| 14 | 2016 | 41 | |
| 15 | 2015 | 35 | |
| 16 | 2017 | 28 | |
| 17 | Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling. | 2016 | 26 |
| 18 | 2014 | 24 | |
| 19 | 2018 | 24 | |
| 20 | 2012 | 24 |
About Jianjun Peng
Jianjun Peng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (14 papers), Cancer-related molecular mechanisms research (9 papers), Genetic factors in colorectal cancer (7 papers), Circular RNAs in diseases (7 papers), Cancer Mechanisms and Therapy (7 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Cancer Research (584 citations), Oncology (372 citations), Molecular Biology (771 citations), Pulmonary and Respiratory Medicine (314 citations) and Gastroenterology (48 citations). Jianjun Peng has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yulong He, Jianbo Xu, Hui Gao, Xinde Ou, Jinning Ye, Shirong Cai, Zirui Zhao, Kaiming Wu, Haohan Liu and Weigang Dai. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer, Oncotarget, BMC Cancer and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.